Evidence map›Paper›PMID 27509238›Full record

ArticleAIDS patient care and STDs2016

Challenges in Recruiting People Who Use Drugs for HIV-Related Biomedical Research: Perspectives from the Field.

Pedro Batista, Sherry Deren, Angela Banfield, Evelyn Silva, Mario Cruz, Preston Garnes, Charles M Cleland, Saurabh Mehandru, Melissa LaMar, Martin Markowitz

Abstract read
In one paragraph

Article in AIDS patient care and STDs, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Pedro Batista1 Center for Drug Use and HIV Research, New York University Rory Meyers College of Nursing , New York, New York.
Sherry Deren1 Center for Drug Use and HIV Research, New York University Rory Meyers College of Nursing , New York, New York.
Angela Banfield2 Manhattan-Staten Island Area Health Education Center, Inc. , New York, New York.
Evelyn Silva1 Center for Drug Use and HIV Research, New York University Rory Meyers College of Nursing , New York, New York.
Mario Cruz3 Harlem United , New York, New York.
Preston Garnes4 New York City Department of Health and Mental Hygiene , New York, New York.
Charles M Cleland1 Center for Drug Use and HIV Research, New York University Rory Meyers College of Nursing , New York, New York.
Saurabh Mehandru5 Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine , New York, New York.
Melissa LaMar6 Aaron Diamond AIDS Research Center and The Rockefeller University , New York, New York.
Martin Markowitz6 Aaron Diamond AIDS Research Center and The Rockefeller University , New York, New York.
New York College of Health Professions · USAaron Diamond AIDS Research Center · USHarlem United · USIcahn School of Medicine at Mount Sinai · USNew York City Department of Health and Mental Hygiene · USStaten Island University Hospital · US

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUsR01DA033777 · NIDA · AARON DIAMOND AIDS RESEARCH CENTER · PI MARKOWITZ, MARTIN H · 2012 to 2016
$4.7M
Post exposure prophylaxis among IDU syringe customers-Pharmacy pilot interventionR01DA030253 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AMESTY, SILVIA, LEWIS, CRYSTAL FULLER · 2010 to 2014
$3.5M
Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical TrialsR01AI070005 · NIAID · NEW YORK UNIVERSITY · PI GWADZ, MARYA · 2007 to 2010
$2.8M
NIAID NIH HHS R01 AI070005NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA030253NIDA NIH HHS R01 DA033777
6 · The paper itself

Abstract

Recruitment of people who use drugs (PWUD) for HIV-related research has been undertaken since early in the epidemic. In early studies, recruitment was often performed by outreach workers with familiarity with the target population, who distributed risk reduction materials, and administered the surveys being conducted on drug use and risk behaviors. The evolution of effective treatments for HIV has provided opportunities for PWUD to participate in biobehavioral studies testing the efficacy of medical treatment advances and exploring the underlying biomedical basis for prevention and treatment efforts. Recruitment for these studies has led to new challenges for outreach workers and institutions conducting this research. PWUD, particularly those from race/ethnic minority populations, have had lower rates of engagement in HIV care and have been underrepresented in HIV/AIDS medical studies. To address these health disparities, enhanced efforts are needed to increase their participation in biomedical studies. This article examines the challenges identified by experienced outreach workers in recruiting PWUD for HIV-related biomedical studies, including individual (participant)-, institutional-, and recruiter-level challenges, and provides recommendations for addressing them.

Indexed as

Biomedical ResearchClinical Trials as TopicDrug UsersHIV InfectionsPatient SelectionSubstance-Related DisordersEthnicityHealthcare DisparitiesHumansMaleMinority GroupsRacial GroupsRisk Reduction BehaviorRisk-TakingSurveys and QuestionnairesVulnerable Populations

Identifiers

PMID27509238
PMCPMC4991596
OpenAlexW2514419363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.